We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00748475
Recruitment Status : Completed
First Posted : September 8, 2008
Last Update Posted : February 20, 2013
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The purpose of the study is to examine the effect of alpha-neurofeedback while subjects listen to a noise on tinnitus.

Condition or disease Intervention/treatment
Tinnitus Behavioral: Neurofeedback

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 12 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus
Study Start Date : September 2008
Primary Completion Date : May 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tinnitus
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Neurofeedback Behavioral: Neurofeedback


Outcome Measures

Primary Outcome Measures :
  1. Reduction of tinnitus distress using the Tinnitus Questionaire [ Time Frame: Before the first and after the last session. ]
  2. Cortical Alpha Power [ Time Frame: Before the first and after the last session ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Duration of Tinnitus >= 6 months and <= 20 years
  • Subjective Tinnitus

Exclusion Criteria:

  • History of neurological or more than mild psychiatric diseases
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00748475


Sponsors and Collaborators
University of Konstanz
Investigators
Principal Investigator: Nathan Weisz, PhD University Konstanz
Study Chair: Thomas Hartmann, Dipl.-Psych. University Konstanz
More Information

Responsible Party: Nathan Weisz, Dr. Nathan Weisz, University of Konstanz
ClinicalTrials.gov Identifier: NCT00748475     History of Changes
Other Study ID Numbers: TE0602-1
First Posted: September 8, 2008    Key Record Dates
Last Update Posted: February 20, 2013
Last Verified: February 2013

Additional relevant MeSH terms:
Tinnitus
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms